Yeager, Samantha
Abramovitz, Daniela
Harvey-Vera, Alicia Yolanda
Vera, Carlos F.
Algarin, Angel Blake
Smith, Laramie Rae
Rangel, Gudelia
Artamonova, Irina
Patterson, Thomas Leroy
Bazzi, Angela Robertson
Brugman, Emma L.
Strathdee, Steffanie Ann
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA049644, R01DA049644, R01DA049644, R01DA049644, T32DA023356, R01DA049644, R01DA049644, R01DA049644, K01DA043412, R01DA049644, R01DA049644)
Fogarty International Center (R21DA051951)
Article History
Received: 10 January 2022
Accepted: 18 April 2022
First Online: 27 April 2022
Declarations
:
: This study was reviewed by the University of California San Diego Office of IRB Administration and the University of Xochicalco Institutional Review Board. All methods were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all participants of the study.
: Not applicable.
: Authors declare that they have no competing interests.